Possible mechanism of vascular reocclusion after initially successful thrombolysis with recombinant tissue-type plasminogen activator
- 18 June 1991
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 121 (6) , 1618-1627
- https://doi.org/10.1016/0002-8703(91)90004-2
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Inhibitory effects of endothelial cells and calcium channel blockers on platelet aggregation.Japanese Heart Journal, 1990
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.Circulation, 1988
- Experiences with pro-urokinase and potentiation of its fibrinolytic effect by urokinase and by tissue plasminogen activatorJournal of the American College of Cardiology, 1987
- Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: Initial patency and influence of maintained infusion on reocclusion rateThe American Journal of Cardiology, 1987
- Tissue-type plasminogen activator and streptokinase induce platelet hyperaggregability in the rabbitThrombosis Research, 1987
- Characterization and fibrin-binding properties of different molecular forms of pro-urokinase from a monkey kidney cell cultureThrombosis Research, 1986
- Platelet activation.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- “In vitro” activity of urokinase on platelet function and on ADP degradation by vascular tissueThrombosis Research, 1982